Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VX-548 by Vertex Pharmaceuticals for Peripheral Neuropathic Pain: Likelihood of Approval
VX-548 is under clinical development by Vertex Pharmaceuticals and currently in Phase II for Peripheral Neuropathic Pain. According to GlobalData,...